PATENT CLAIM ANALYSIS

Application Number: 16206953
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "452000"]

Abstract:
Methods for individualized therapy of arthritic pain using a non-steroidal anti-inflammatory drug (COX-2 inhibitor). Said methods comprise basing COX-2 inhibitor dose on each patient's pharmacokinetic response to said COX-2 inhibitor.

Claim (Index 14):
The method of  claim 13 , wherein the dose of celecoxib and hydrochlorothiazide in a single dosage unit is 100 mg celecoxib and 12.5 mg hydrochlorothiazide, 200 mg celecoxib and 12.5 mg hydrochlorothiazide, 100 mg celecoxib and 25 mg hydrochlorothiazide, or 200 mg celecoxib and 25 mg hydrochlorothiazide.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12426530', '14619634', '15589158', '16054578', '10158216']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.750349965457992
- 35 USC 102 Novelty (BERT): 0.5055156748798633
- Combined Prediction Score: 0.7258665364001792
- Mean Citation Score: 231.748518
- Max Citation Score: 249.41182
- Similarity Product: 167.83981846604587

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test